Data / Form D filings / Eumentis Therapeutics, Inc.
Eumentis Therapeutics, Inc.: Form D filings
Eumentis Therapeutics, Inc., a pharmaceuticals company in Newton, MA, filed 4 Form D notices with the SEC between 2020 and 2024. The latest, on June 26, 2024, reports $765,000 sold of a $2 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 508 DUDLEY ROAD, SUITE 105, Newton, MA, 02459
- Phone
- (617) 413-3020
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1823359
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 26, 2024 | New notice | $2,000,000 | $765,000 | $1,235,000 | 11 | Aug 16, 2021 | sec.gov |
| Mar 17, 2023 | New notice | $20,000,000 | $4,000,000 | $16,000,000 | 1 | Yet to occur | sec.gov |
| Apr 15, 2022 | New notice | $5,000,000 | $5,000,000 | 1 | Apr 13, 2022 | sec.gov | |
| Sep 2, 2020 | New notice | $3,300,000 | $1,500,000 | $1,800,000 | 25 | Aug 14, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Maryann Bryla | Director | |
| James Larrick | Director | |
| Randall Marshall | Executive Officer | |
| Kim Patrick | Director | |
| Mark Tepper | Executive Officer, Director | |
| Andrew Pearlman | Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jun 24, 2024 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Eumentis Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.